All

Results: 9169-9180 of 77086

Energy Vault Enters Japanese Market with Acquisition of 850 MW Energy Storage Portfolio, Set to Capture One of the World’s Fastest-Growing Energy Storage Markets

£50 million boost for defence businesses in Plymouth and the South West with new defence growth deal

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

PR Newswire associated0

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

PR Newswire associated0

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

Lee Cronin, CEO and founder of Chemify, the deep-tech pioneer of Chemputation – a technological breakthrough that integrates AI- and ML-driven molecular discovery and automated, robotic synthesis – has published three peer-reviewed research papers in close succession, constituting a technological tour de force that validates Chemputation as a new paradigm for how small molecule-drugs and materials are discovered, designed and manufactured. The three publications in PNAS, Nature Communications Chemistry and Nature Communications Biology describe how the Chemputation AI platform can understand and execute instructions to make new molecules from scientific literature, produce them iteratively and how this could be applied to cancer research.

Chemify Founder Publishes Three Papers Validating Chemputation To Reimagine New Chemical Discovery and Development

INTRODUCING NATURE'S WELLNESS SANCTUARY AT 1 HOTEL HANALEI BAY

Clivet Sets Out Sustainability Roadmap Ahead of New EU Building Rules Coming into Effect

PR Newswire associated0

REHLKO AND INNIO ENTER INTO MULTI‑YEAR 1.25 GW ENGINE FRAMEWORK AGREEMENT TO SUPPORT ACCELERATING GLOBAL DATA CENTER AND FLEXIBLE GENERATION DEMAND

PR Newswire associated0

Appknox Launches KnoxIQ, an AI Co-Pilot to Prioritize Real-World Exploitability in Application Security

DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development

PR Newswire associated0

Miami International Holdings Announces the Passing of Board Member Murray Stahl